Paroxetine and amitriptyline in the treatment of depression in general practice

Acta Psychiatrica Scandinavica

Volumn 93, Issue 3, 1996, Pages 158-163

  Christiansen, P E ^a,d   Behnke, K ^a   Black, C H ^b   Ohrstrom J K ^c   Bork Rasmussen, H ^a   Nilsson, J ^b  

^a Novo Nordisk A/S ^*

^b NOVO NORDISK A S   (Denmark)

^c NOVO NORDISK INC   (United States)

^d NONE   (Denmark)

Author keywords

amitriptyline; depression; paroxetine

Indexed keywords

AMITRIPTYLINE; PAROXETINE;

ADULT; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; FATIGUE; FEMALE; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; XEROSTOMIA;

EID: 0030001843     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1996.tb10623.x     Document Type: Article

References (9)

1. BECH P. Acute therapy of depression. J Clin Psychiatry 1993: 54: (Suppl. 8): 18-27.
2. FEIGHNER JP. Clinical overview of serotonin re-uptake inhibitors. Nord J Psychiatry 1992: 46: Suppl. 27, 7-16.
3. DUNBAR GC. Aspects of tolerability and safety for paroxetine. Nord J Psychiatry 1992: 46: Suppl. 27, 41-46.
4. WARRINGTON SJ, LEWIS Y. Cardiovascular effects of antidepressants: Studies of paroxetine in healthy men and depressed patients. International Clinical Psychopharmacology 1992: 6: Suppl. 4, 59-67.
5. JENNER PN. Paroxetine: An overview of dosage, tolerability and safety International Clinical Psychopharmacology 1992: 6: Suppl. 4, 59-67.
6. KESSLER RC, MCGONAGLE KA, ZHAO S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psych 1994: 51: 8-19.
7. DUNBAR GC, RASMUSSEN JGC, FUELL DL. An overview of the tolerability and safety of paroxetine in depressed patients: 5th World Congress of biological psychiatry, Florence, June, 1991, 20-21.
8. MÖLLER HJ, BERZEWSKI H, ECKMANN F et al. Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients. Pharmacopsychiat 1993: 26: 75-78.
9. BIGNAMINI A, RAPISARDA V. Double-blind multicenter study of paroxetine and amitriptyline in depressed outpatients. International Clinical Psychopharmacology 1992: 6: Suppl. 4, 37-41.